Typicality: | 0.145 |
Saliency: | 0.338 |
specifically | 17 | manner |
in women | 6 | other |
tuesday | 2 | temporal |
drug → treat → postpartum depression | 20 |
drug → be designed to treat → postpartum depression | 9 |
drug → be developed for → postpartum depression | 5 |
drug → be developed to treat → postpartum depression | 4 |
negative | neutral | positive |
0.095 | 0.432 | 0.473 |
Raw frequency | 38 |
Normalized frequency | 0.338 |
Modifier score | 0.000 |
Perplexity | 35.108 |